Relation between maternal thrombophilia and stillbirth according to causes/associated conditions of death

Early Human Development

Volumn 88, Issue 4, 2012, Pages 251-254

  Monari, F ^a   Alberico, S ^b   Avagliano, L ^c   Cetin, I ^d   Cozzolino, S ^e   Gargano, G ^a   Marozio, L ^f   Mecacci, F ^g   Neri, I ^a   Tranquilli, A L ^h   Venturini, P ^a   Facchinetti, F ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF MILANO BICOCCA   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

^g UNIVERSITY OF FLORENCE   (Italy)

^h UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Acquired thrombophilia; Factor II mutation; Factor V Leiden; Placenta vascular disorders; Stillbirth

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PROSPECTIVE STUDY; SOLUTIO PLACENTAE; STILLBIRTH; THROMBOPHILIA;

ADULT; CASE-CONTROL STUDIES; CAUSE OF DEATH; FEMALE; FETAL DISEASES; FETAL MORTALITY; HUMANS; INFANT, NEWBORN; MALE; PLACENTA DISEASES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; SOCIOECONOMIC FACTORS; STILLBIRTH; THROMBOPHILIA; YOUNG ADULT;

EID: 84858342895     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2011.08.013     Document Type: Article

References (31)

1. Rodger M.A., Paidas M., Mc Lintock C., Middeldorp S., Kahn S., Martinelli I., Hague W., Rosene Montella K., Greer I. Inherited thrombophilia and pregnancy complications revisited. Obstet Gynecol 2008, 112:320-324.
2. Middeldorp S.J. Thrombophilia and pregnancy complications: cause or association?. Thromb Haemost 2007, 5(Suppl 1):276-285.
3. Weiner Z., Younis J.S., Blumenfeld Z., Shalev E. Assessment of uterine placental circulation in thrombophilic women. Semin Thromb Hemost 2003, 29:213-218.
4. De Groot P.G., Derksen H.V.M. Pathophysiology of the antiphospholipid syndrome. J Thromb Haemost 2005, 3:1854-1860.
5. Smith G.C.S., Fretts R.C. Stillbirth. Lancet 2007, 370:1715-1725.
6. Facchinetti F., Reddy U., Stray-Pedersen B., Baronciani D., Requejo J.H. Stillbirth International Group. International issues in stillbirth. J Matern-Fetal Neonatal Med 2008 Jun, 21(6):425-428.
7. Goldenberg R.L., Kirby R., Culhane J.F. Stillbirth: a review. J Mat Fet Neonat Med 2004, 16:79-94.
8. Simpson L.L. Maternal medical diseases: risk of antepartum fetal death. Semin Perinatol 2002, 26:42-50.
9. Getaun D., Ananth C.V., Kinzler W.L. Risk factors for antepartum and intrapartum stillbirth: a population-based study. Am J Obstet Gynaecol 2007, 196:499-507.
10. Fretts R.C. Etiology and prevention of stillbirth. Am J Obstet Gynaecol 2005, 193:1923-1935.
11. Rey E., Kahn S.R., David M., Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003, 361:901-908.
12. Robertson L., Wu O., Langhorne P., Twaddle S., Clark P., Lowe G.D., et al. The thrombosis: risk and economic assessment of thrombophilia screening (TREATS) study. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006, 132:171-196.
13. Flenady V., Frøen J.F., Pinar H., Torabi R., Saastad E., Guyon G., et al. An evaluation of classification systems for stillbirth. BMC Pregnancy Childbirth 2009 Jun 19, 9:24.
14. ACOG Committee on Obstetric Practice ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynecol Obstet 2002, 77:67-75.
15. Bertina R.M., Koeleman B.P.C., Koster T., Rosendaal F.R., Dirven R.J., deRonde H., Van der Velden P.A., Reitsma P.H. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994, 369:64-67.
16. Poort S.R., Rosendaal F.R., Reitsma P.H., Bertina R.M. A common genetic variation in the 3-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996, 88:3698-3703.
17. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999, 42:1309-1311.
18. Mello G., Parretti E., Marozio L., Pizzi C., Lojacono A., Frusca T., et al. Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study. Hypertension 2005, 46:1270-1274.
19. Martinelli I., Taioli E., Cetin I., Marinoni A., Gerosa S., Villa M.V., et al. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 2000 Oct 5, 343(14):1015-1018.
20. Many A., Elad R., Yaron Y., Eldor A., Lessing J.B., Kupferminc M.J. Third-trimester unexplained intrauterine fetal death is associated with inherited thrombophilia. Obstet Gynecol 2002 May, 99(5 Pt 1):684-687.
21. Gris J.C., Quéré I., Monpeyroux F., Mercier E., Ripart-Neveu S., Tailland M.L., et al. Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent-the Nîmes Obstetricians and Haematologists Study 5 (NOHA5). Thromb Haemost 1999 Jun, 81(6):891-899.
22. Alonso A., Soto I., Urgellés M.F., Corte J.R., Rodríguez M.J., Pinto C.R. Acquired and inherited thrombophilia in women with unexplained fetal losses. Am J Obstet Gynecol 2002, 187:1337-1342.
23. Silver R.M., Zhao Y., Spong C.Y., Sibai B., Wendel G., Wenstrom K., Samuels P., Caritis S.N., Sorokin Y., Miodovnik M., O'Sullivan M.J., Conway D., Wapner R.J. Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol 2010, 115:14-20. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units (NICHD MFMU) Network.
24. Korteweg F.J., Erwich J.J., Folkeringa N., Timmer A., Veeger N.J., Ravisé J.M., et al. Prevalence of parental thrombophilic defects after fetal death and relation to cause. Obstet Gynecol 2010 Aug, 116:355-364.
25. Said J.M., Higgins J.R., Moses E.K., Walker S.P., Borg A.J., Monagle P.T., et al. Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women. Obstet Gynecol 2010, 115:5-13.
26. Rodger M.A., Betancourt M.T., Clark P., Lindqvist P.G., Dizon-Townson D., Said J., et al. The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies. PLoS Med Jun 15 2010, 7(6):e1000292. Review.
27. Facchinetti F., Marozio L., Frusca T., Grandone E., Venturini P., Tiscia G.L., et al. Maternal thrombophilia and the risk of recurrence of preeclampsia. Am J Obstet Gynecol 2009, 200:46.e1-46.e5.
28. Infante-Rivard C., Rivard G.E., Yotov W.V., Génin E., Guiguet M., Weinberg C., et al. Absence of association of thrombophilia polymorphisms with intrauterine growth restriction. N Engl J Med 2002 Jul 4, 347(1):19-25.
29. Ariel I., Anteby E., Hamani Y., Redline R.W. Placental pathology in fetal thrombophilia. Hum Pathol 2004, 35:729-733.
30. Salomon O., Seligsohn U., Steinberg D.M., Zalel Y., Lerner A., Rosenberg N., et al. The common prothrombotic risk factors in nulliparous women do not compromise blood flow in the feto-maternal circulation and are not associated with preeclampsia or intrauterine growth restriction. Am J Obstet Gynecol 2004, 191:2002-2009.
31. Monari F., Facchinetti F. Management of subsequent pregnancy after antepartum stillbirth. A review. J Matern Fetal Neonatal Med 2010, 23:1073-1084.